Table 2.
Survival estimates for all patients
| Group | Total | Number of failed | Median survival in months (95% CI) | 6-month survival (95% CI) | 12-month survival (95% CI) | 24-month survival (95% CI) | Logrank P-value | |
|---|---|---|---|---|---|---|---|---|
| OS | All | 21 | 10 | 66 (20.7, 66) | 85.7 (62, 95.2) | 81 (56.9, 92.4) | 66.7 (42.5, 82.5) | |
| Grade I | 8 | 2 | 66.0 (42, 66) | 100 | 100 | 100 | 0.018 | |
| Grade II/III | 13 | 8 | 20.9 (4.6, ∞) | 76.9 (44.2, 91.9) | 69.2 (37.3, 87.2) | 46.2 (19.2, 69.6) | ||
| PFS | All | 21 | 20 | 7 (3.8, 9.2) | 61.9 (38.1, 78.8) | 23.8 (8.7, 43.1) | 9.5 (1.6, 26.1) | |
| Grade I | 8 | 8 | 13.9 (4.1, 20.3) | 87.5 (38.7, 98.1) | 50 (15.2, 77.5) | 12.5 (0.7, 42.3) | 0.025 | |
| Grade II/III | 13 | 12 | 5.3 (1.8, 7) | 46.2 (19.2, 69.6) | 7.7 (0.5, 29.2) | 7.7 (0.5, 29.2) |
OS overall survival, PFS progression-free survival, CI confidence interval